AU3894299A - Compositions comprising 2-phenyl-indole compounds and estrogen formulations - Google Patents

Compositions comprising 2-phenyl-indole compounds and estrogen formulations

Info

Publication number
AU3894299A
AU3894299A AU38942/99A AU3894299A AU3894299A AU 3894299 A AU3894299 A AU 3894299A AU 38942/99 A AU38942/99 A AU 38942/99A AU 3894299 A AU3894299 A AU 3894299A AU 3894299 A AU3894299 A AU 3894299A
Authority
AU
Australia
Prior art keywords
phenyl
compositions
indole compounds
estrogen formulations
estrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38942/99A
Inventor
Barry Samuel Komm
James Harrison Pickar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of AU3894299A publication Critical patent/AU3894299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
AU38942/99A 1998-05-15 1999-05-11 Compositions comprising 2-phenyl-indole compounds and estrogen formulations Abandoned AU3894299A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US7960498A 1998-05-15 1998-05-15
US7964498A 1998-05-15 1998-05-15
US09079604 1998-05-15
US09079644 1998-05-15
PCT/US1999/010215 WO1999059969A1 (en) 1998-05-15 1999-05-11 Compositions comprising 2-phenyl-indole compounds and estrogen formulations

Publications (1)

Publication Number Publication Date
AU3894299A true AU3894299A (en) 1999-12-06

Family

ID=26762198

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38942/99A Abandoned AU3894299A (en) 1998-05-15 1999-05-11 Compositions comprising 2-phenyl-indole compounds and estrogen formulations

Country Status (6)

Country Link
EP (1) EP1080073A1 (en)
JP (1) JP2002515484A (en)
CN (1) CN1309637A (en)
AU (1) AU3894299A (en)
CA (1) CA2331318A1 (en)
WO (1) WO1999059969A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1990051A1 (en) * 2000-07-06 2008-11-12 Wyeth Combinations of SSRI and estrogenic agents
CN1468110A (en) * 2000-07-06 2004-01-14 惠氏公司 Combinations of statins, estrogenic agents and optionally estrogens
EP1656938A1 (en) * 2000-07-06 2006-05-17 Wyeth Combinations of SSRI and estrogenic agents
WO2002003989A2 (en) * 2000-07-06 2002-01-17 Wyeth Use of substituted indole compounds for treating sphincter incontinence
US6376486B1 (en) 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
EP1299093A2 (en) * 2000-07-06 2003-04-09 Wyeth Combinations of bisphosphonates, estrogenic agents and optionally estrogens
US6455568B2 (en) 2000-07-06 2002-09-24 Wyeth Combination therapy for inhibiting sphincter incontinence
WO2002003992A2 (en) * 2000-07-06 2002-01-17 Wyeth Use of substituted indole compounds for treating prosthesis-related bone degeneration
JP2004524354A (en) * 2001-03-16 2004-08-12 ワイス Estrogen replacement therapy
DE10117441A1 (en) * 2001-04-03 2002-10-10 Schering Ag 1-indolyl derivatives, their use in the manufacture of medicaments, a process for the preparation of 1-indolyl derivatives and pharmaceutical preparations containing 1-indolyl derivatives
WO2002094268A1 (en) 2001-05-22 2002-11-28 Eli Lilly And Company Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen
WO2002094788A1 (en) 2001-05-22 2002-11-28 Eli Lilly And Company 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
CA2448235A1 (en) 2001-07-31 2003-02-13 Pfizer Products Inc. Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
US20040002604A1 (en) 2001-12-10 2004-01-01 Richard Apodaca Phenylalkynes
EA200400661A1 (en) 2001-12-10 2004-12-30 Орто-Макнейл Фармасьютикал, Инк. Phenylalkins
BR0316971A (en) * 2002-12-02 2005-10-25 Ortho Mcneil Pharm Inc Phenylalkines
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
CN104098499B (en) * 2013-04-08 2016-05-04 上海医药工业研究院 The preparation method of 5-benzyloxy-2-(4-benzyloxy phenyl)-3-Methyl-1H-indole

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30747A (en) * 1989-03-10 1997-10-17 Endorech Inc Combination therapy for the treatment of estrogen sensitive disease.
CA2135160A1 (en) * 1992-05-08 1993-11-25 Masatoshi Inai Indole derivative
DE4335876A1 (en) * 1993-10-17 1995-04-20 Schering Ag Combination of progesterone antagonists and partial agonist antiestrogens for hormone replacement therapy for peri- and postmenopausal women
JP3536258B2 (en) * 1994-02-22 2004-06-07 メレルファーマスーティカルズ インコーポレイテッド Novel indole derivatives useful in the treatment of neoplasms and diseases associated with estrogen
DE4426625A1 (en) * 1994-07-27 1996-03-14 Schering Ag 2-phenylindoles, processes for their preparation, pharmaceutical preparations containing them and their use in the manufacture of medicaments
US5552401A (en) * 1995-02-28 1996-09-03 Eli Lilly And Company 2-benzyl-3-arylbenzothiophenes
EP0802183B1 (en) * 1996-04-19 2001-10-10 American Home Products Corporation Estrogenic agents
TW397821B (en) * 1996-04-19 2000-07-11 American Home Produits Corp 3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof

Also Published As

Publication number Publication date
EP1080073A1 (en) 2001-03-07
JP2002515484A (en) 2002-05-28
WO1999059969A1 (en) 1999-11-25
CA2331318A1 (en) 1999-11-25
CN1309637A (en) 2001-08-22

Similar Documents

Publication Publication Date Title
AU3949999A (en) Perfume compositions
AU5982999A (en) Antiperspirant compositions
AU7717498A (en) Odor reducing compositions
AU4911199A (en) Cosmetic composition
AU2557800A (en) Preservative compounds and compositions
AU4413299A (en) Stabilized pharmaceutical compositions
AU9361398A (en) Perfume compositions
AU3894299A (en) Compositions comprising 2-phenyl-indole compounds and estrogen formulations
AU2349399A (en) R-lansoprazole compositions and methods
AU3469899A (en) Particulate compositions
AU7666898A (en) Surfactant compositions
AU1625100A (en) Soluble complex alcohol ester compounds and compositions
AU8053898A (en) Immunogenic compositions
AU3835399A (en) Perfume composition
AUPP589398A0 (en) Immunogenic compositions and uses thereof
AU5575398A (en) Hairdye compositions
AU4834200A (en) Fatty acid-n-substituted indol-3-glyoxyl-amide compositions and uses thereof
AU6256298A (en) Cosmetic compositions
AU7816000A (en) Pediculocidal and veterinary compositions
AU2899899A (en) Cosmetic compositions
AU6217199A (en) Compositions
AU3558799A (en) Flutamide compositions and preparations
AU1063699A (en) Release compositions
AU1316199A (en) Cosmetic compositions
AU3900499A (en) (+)-hydroxyrisperidone compositions and methods

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase